The effect of enterolactone on liver lipid precursors of inflammation.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Mar 2019
Historique:
received: 09 01 2019
revised: 20 02 2019
accepted: 21 02 2019
pubmed: 26 2 2019
medline: 4 4 2019
entrez: 26 2 2019
Statut: ppublish

Résumé

The aim of this study was to assess the effects of enterolactone (ENL) on lipid fractions fatty acids composition affecting hepatocyte inflammation development. The experiments were conducted in HepG2 cells incubated with ENL and/or palmitic acid (16 h). Intracellular contents of free fatty acids (FFA), di- (DAG) and tri- (TAG) acylglycerol as well as their fatty acids compositions were assessed by Gas-Liquid Chromatography. Moreover, the ω-6/ω-3 ratios in the above mentioned lipids fractions were estimated. The expression of proteins involved in eicosanoids and prostanoids production (COX-2, 15-LOX), inflammatory process (TNFα), as well as the proteins participating in the desaturation (SCD 1) and elongation (Elovl 3, Elovl 6) of fatty acids were evaluated by Western Blot. Enterolactone modified fatty acids composition in FFA, DAG and TAG fractions. In conjunction with lipid overload, it increased the content of ω-6 more than ω-3 PUFA. Moreover, it enhanced the expressions of Elovl 3, Elovl 6, COX-2 and TNFα, whereas it had no influence on SCD 1 and 15-LOX level. Our study revealed that the supplementation with ENL affected intracellular hepatic composition of saturated as well as unsaturated fatty acids in each of the investigated lipid fractions. Based on the shift in the ω-6/ω-3 balance towards ω-6, as well as the increase in COX-2 and TNFα protein expressions, we may postulate a pro-inflammatory nature of the examined polyphenol. Moreover, our findings could prove to be useful in the future research in the topic of widespread diseases such as NASH.

Identifiants

pubmed: 30802511
pii: S0024-3205(19)30134-1
doi: 10.1016/j.lfs.2019.02.044
pii:
doi:

Substances chimiques

Eicosanoids 0
Fatty Acids 0
Fatty Acids, Nonesterified 0
Fatty Acids, Omega-3 0
Fatty Acids, Unsaturated 0
Lignans 0
Lipids 0
Prostaglandins 0
Triglycerides 0
Palmitic Acid 2V16EO95H1
4-Butyrolactone OL659KIY4X
2,3-bis(3'-hydroxybenzyl)butyrolactone X01E7E1D6H

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

341-347

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Klaudia Berk (K)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland.

Krzysztof Drygalski (K)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland.

Ewa Harasim-Symbor (E)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland.

Tomasz Charytoniuk (T)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland.

Nicoletta Iłowska (N)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland.

Bartłomiej Łukaszuk (B)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland.

Adrian Chabowski (A)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland.

Karolina Konstantynowicz-Nowicka (K)

Department of Physiology, Medical University of Bialystok, Mickiewicza St. 2C, 15-222 Bialystok, Poland. Electronic address: karolina.konstantynowicz@umb.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH